← Back to All Filings

UiPath Officer Reports Sale of $170K in PATH Stock

Low SignificanceOctober 14, 2025 at 8:07:28 AM EDT

UiPath, Inc.

$PATH144CIK: 0001734722

Subscribe to track PATH

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

UiPath Officer Reports Sale of $170K in PATH Stock

Company: UiPath, Inc. (PATH) Form: 144 | Filed: 2025-10-14 Significance: Low

Insider: Hitesh Ramani Title: Officer | Relationship: Officer

Transaction: • Type: Sale • Shares: 10,000 • Price: $17.05 • Value: $170,500 • Owned After: Not Disclosed

Key Insight: An officer at UiPath reported the sale of 10,000 shares. The total value of the transaction is relatively small, suggesting it may be for personal financial planning rather than a change in outlook on the company.

Market Context: This Form 144 filing serves as a notice of proposed sale. The sale was executed under a pre-arranged trading plan adopted on July 14, 2025.

View Full Filing

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: UiPath, Inc. (PATH)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: An officer of UiPath, Hitesh Ramani, has filed a Form 144 indicating the sale of 10,000 shares of common stock for a total value of approximately $170,500.
  • Market Impact: The impact is expected to be neutral to minimal. The transaction size is not substantial enough to signal a significant change in insider sentiment, and the sale appears to be planned.

Company Information

FieldValue
CompanyUiPath, Inc.
Ticker SymbolPATH
CIK0001734722
IndustrySERVICES-PREPACKAGED SOFTWARE [7372]

Insider Information

FieldValue
NameHitesh Ramani
CIK0001855764
Title/PositionOfficer
RelationshipOfficer

Transaction Details

FieldValue
Form Type144
Transaction Date2025-10-13
Transaction CodeS (Sale)
Security TypeCommon Stock
Shares Involved10,000
Price Per Share$17.05
Total Value$170,500.00
Shares Owned AfterNot Disclosed
Ownership TypeNot Disclosed

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: A sale of this size by an officer is unlikely to move the market. It represents a very small fraction of the total shares outstanding (453,568,899). Such sales are common for executive liquidity, tax obligations, or portfolio diversification.

Volume & Sentiment

  • Expected Volume Impact: Negligible. The transaction size is too small to significantly affect daily trading volume.
  • Sentiment Indicator: Neutral. The filing indicates the sale was planned in advance (plan adoption date of July 14, 2025), which mitigates any negative sentiment that might arise from an unplanned insider sale.

Investment Insights

Positive Market Indicators

  • The sale was conducted under a pre-arranged plan, which reduces concerns about it being based on negative near-term information.

Risk Factors

  • While this single transaction is not concerning, a pattern of multiple insider sales could be a bearish signal. This event should be monitored in the context of future insider activity.

Key Takeaways

  1. Low Significance Sale: The $170,500 sale is not material for an officer of a multi-billion dollar company.
  2. Planned Transaction: The sale was made under a plan adopted months prior, indicating it was not a spontaneous decision based on recent events.
  3. Form 144 Context: This form is a notice of intent to sell restricted securities. The filing confirms the sale was executed on the transaction date.

Contextual Analysis

Timing Significance

  • The sale occurred on October 13, 2025, and was filed the next business day. The timing does not appear to coincide with any major negative company-specific news, reinforcing the idea of a routine transaction.

Transaction Context

  • The filing's remarks state the shares were acquired through the vesting of restricted stock units (RSUs). It is common for executives to sell a portion of vested RSUs to cover tax liabilities or for personal financial management. The filing also notes a plan adoption date of July 14, 2025, suggesting this may be part of a 10b5-1 trading plan.

Company Context

  • UiPath operates in the robotic process automation (RPA) and AI software space. Analysis of this filing should be paired with a broader look at the company's recent performance, earnings reports, and competitive landscape.

Risk Assessment

Risk Level: Low

Risk Factors

  • Signal Misinterpretation: Retail investors might incorrectly interpret any insider sale as a negative sign without considering the context of size and planning.
  • Pattern Development: This sale is benign on its own, but it contributes to the overall picture of insider activity. A trend of sales could become a concern.

Market Considerations

  • Tech Sector Sentiment: The broader sentiment in the technology and software sectors can influence how even minor insider sales are perceived.
  • Company Performance: The stock's recent performance is a key factor. A sale into strength is less concerning than a sale during a period of stock price weakness.

IMPORTANT DISCLAIMER: This analysis is for informational purposes only and is not intended as investment advice. The information presented is based on publicly available SEC filings and should not be construed as a recommendation to buy, sell, or hold any securities. Past performance does not guarantee future results. All investments carry risk, including the potential loss of principal. Please consult with a qualified financial advisor before making any investment decisions.

Analysis generated on 2025-10-14 | Data source: SEC EDGAR

Topics:#UiPath#PATH#InsiderTrading#SECFiling#Form144#InsiderSell#StockMarket#Investing#TechStocks

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.